ClinicalTrialsFinder

Metabolic dysfunction–associated steatotic liver disease (MASLD) Clinical Trials in Sherbrooke, Quebec

1 recruitingSherbrooke, Quebec, Canada

Showing 1–1 of 1 trials

Recruiting
Not Applicable

Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.

Non alcoholic steato hepatitis (NASH)Liver Fibrosis/NASHMetabolic dysfunction–associated steatotic liver disease (MASLD)
Université de Sherbrooke36 enrolled1 locationNCT06843148